Home Data Calendar Blog

MNKD

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Common Stock Value 2.632.572.522.522.502.502.492.422.312.292.132.122.061.891.881.871.591.461.261.191.051.050.964.784.784.784.294.294.184.124.094.064.053.963.873.702.862.001.991.681.311.311.31NA1.28NANA
Weighted Average Number Of Diluted Shares Outstanding 259.30253.64NANA249.91249.29NANANANANANANANANA161.40153.60140.05120.91116.45104.7099.8695.7496.51482.7491.0685.77NA405.20NANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 259.30253.64NANA249.91249.29NANANANANANANANANA161.40153.60140.05120.91116.45104.7099.8695.7495.68478.1491.0685.77NA405.20NANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Share Outstanding Basic And Diluted NANA251.89NA249.91249.29246.63NA229.67213.88212.47206.69199.91188.05187.43161.40153.60140.05120.91NA104.7099.8695.74NANA455.31428.8683.86405.20401.02398.92NA394.16380.77368.78NANANANANANANANANANANANA
Earnings Per Share Basic -0.06-0.11NANA-0.02-0.14NANANANANANANANANA-0.06-0.16-0.16-0.25-0.28-0.31-0.35-0.170.560.26-0.33-0.29-4.31-0.08NANANANANANANANANANANANANANANANANANA
Earnings Per Share Diluted -0.06-0.11NANA-0.02-0.14NANANANANANANANANA-0.06-0.16-0.16-0.25-0.28-0.31-0.35-0.170.560.26-0.33-0.29-4.31-0.08NANANANANANANANANANANANANANANANANANA
Earnings Per Share Basic And Diluted NANA-0.10-0.11-0.02-0.14-0.05-0.12-0.05-0.05-0.04-0.07-0.05-0.07-0.08-0.06-0.16-0.16-0.25NA-0.31-0.35-0.17NANA-0.07-0.06-0.66-0.08-0.07-0.08-0.09-0.09-0.19-0.14-0.16-0.23-0.22-0.23-0.27-0.30-0.31-0.37-0.34-0.33-0.40-0.37

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenue From Contract With Customer Excluding Assessed Tax 32.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Revenues 32.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Cost Of Goods And Services Sold 5.024.622.284.293.814.414.323.653.593.684.164.637.104.334.025.005.305.094.015.024.585.09NANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Expenses 17.4612.91NANA9.899.93NANANANANANANANANANANANANANANANANANANANA20.01272.8626.0024.0521.7430.1038.2769.8541.4146.6233.4935.5244.0533.9330.5832.7739.1938.0532.0942.5437.36
Costs And Expenses 42.4439.3533.2536.4828.8033.5523.6342.1924.4823.0323.3627.3423.3725.9530.9623.7626.0124.4330.2533.3730.2233.7322.6124.2444.1219.1220.01272.8626.0024.05NANANANANANANANANANANANANANANANANA
Research And Development Expense Excluding Acquired In Process Cost 4.144.893.543.893.652.332.441.541.481.461.752.021.581.631.671.082.042.972.643.514.363.123.131.563.924.315.136.226.347.749.3817.5619.1837.3226.1828.9925.2725.4526.6424.1620.2423.1330.3026.2924.2231.4126.16
Selling General And Administrative Expense 22.6426.0420.7022.7317.2220.0617.4117.1213.9013.6714.3515.7216.6716.6125.6717.9819.3921.7320.6223.2817.7318.5715.3915.3313.1311.117.358.3111.5510.62NANANANANANANANANANANANANANANANANA
Operating Income Loss -9.61-20.45-21.26-23.97-6.59-10.27-6.19-23.75-9.13-7.92-7.12-11.35-8.78-10.95-13.51-7.73-21.54-20.54-26.79-28.84-28.18-31.57-19.60-11.83118.23-19.12-20.01-272.86-26.00-24.05-21.74-30.10-38.27-69.85-41.41-46.62-33.49-35.49-44.05-33.93-30.58-32.77-39.19-38.00-32.09-42.54-37.26
Interest Expense Debt 2.816.642.754.262.712.815.421.101.061.081.071.024.130.560.590.620.991.711.792.062.312.422.713.014.174.184.223.334.144.139.625.655.422.434.045.102.862.862.842.582.852.852.832.412.831.881.21
Interest Paid Net 0.800.743.60NA3.825.621.090.701.040.940.89NANANANA0.861.030.001.861.352.231.592.551.792.591.902.711.924.79NANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 3.624.422.813.163.183.931.941.901.292.191.130.891.642.571.001.141.562.211.941.081.251.251.301.001.501.351.272.352.601.772.001.87-4.8340.6410.9413.883.523.823.072.883.183.321.99NANANANA
Profit Loss -14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.16-22.68-30.39-32.78-32.89NANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss -14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.17-22.68-30.39-32.78-32.89-35.34-16.3253.98126.52-29.96-24.87-277.02-31.86-28.91-30.66-36.44-36.52-73.36-52.06-53.58-51.78-42.83-36.58-38.17-36.40-38.40-44.48-41.52-38.31-45.30-42.25
Comprehensive Income Net Of Tax -14.43-29.15-27.07-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.34-14.26-10.37-12.39-14.88-9.75-24.17-22.68-30.38-32.78-32.88-35.34-16.3253.97126.52-29.96-24.87-277.02-31.86-28.91-30.66-36.44-36.53-73.36-52.06-53.58-51.79-42.84-36.57-38.13-36.40-38.40-44.53-41.54NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets 293.84285.80308.32321.16238.21252.79319.38108.6195.68102.7880.2193.7295.1481.80100.96107.7045.3662.1661.8884.5856.4879.3785.19107.0696.13139.4393.27126.41278.01352.55360.02394.44386.82236.31224.55258.65251.31210.33240.39251.42199.55224.01228.36NA277.26NANA
Liabilities 531.51532.85540.38530.51422.89436.34493.00289.03282.10282.49278.26284.25279.85277.79288.96282.79250.80268.77285.08299.31307.50300.62283.91290.66334.82506.01466.74476.74402.58468.03457.05468.21427.50282.68207.02289.36361.99486.58484.77528.81513.21504.82473.74NA462.79NANA
Liabilities And Stockholders Equity 293.84285.80308.32321.16238.21252.79319.38108.6195.68102.7880.2193.7295.1481.80100.96107.7045.3662.1661.8884.5856.4879.3785.19107.0696.13139.4393.27126.41278.01352.55360.02394.44386.82236.31224.55258.65251.31210.33240.39251.42199.55224.01228.36NA277.26NANA
Stockholders Equity -237.68-247.06-232.06-209.35-184.69-183.55-173.62-180.42-186.42-179.71-198.05-190.53-184.71-196.00-188.00-175.08-205.44-206.62-223.21-214.73-251.01-221.24-198.72-183.59-238.69-366.58-373.46-350.33-124.57-115.47-97.03-73.77-40.68-46.3817.54-30.71-110.68-276.25-244.38-277.39-313.65-280.81-245.38NA-185.53NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets Current 218.38193.48184.26219.74159.21179.90288.3479.4866.3572.5849.3560.7661.7449.8369.6981.8519.5235.8035.0357.2228.6350.9356.0977.4948.6090.7644.1476.6571.24145.83158.29201.15193.5244.9139.4076.2866.8123.2050.3459.715.8227.0226.86NA73.95NANA
Cash And Cash Equivalents At Carrying Value 54.3135.5167.24124.1851.7462.52247.8367.0052.4063.2238.8729.9130.177.9734.5371.1610.4526.1826.7143.9520.0943.3847.9822.8935.5363.7327.6559.0732.93107.19120.84120.84172.4741.2135.7670.7961.841.7631.6456.352.6822.7924.7746.9166.0697.9328.36
Short Term Investments 110.74118.6595.2079.9387.3199.9728.96NANA0.000.0019.9819.8924.9124.76NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accounts Receivable Net Current 23.4915.039.824.999.456.303.574.224.133.375.033.514.094.973.764.022.752.851.552.791.801.310.440.303.14NA0.140.021.684.754.2850.44NANANANANANANANANANANANANANANA
Inventory Net 18.2720.578.047.157.487.485.054.974.883.823.234.163.693.963.723.602.793.683.892.663.133.173.702.33NANANANA23.4019.8216.799.67NANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 11.573.723.953.483.233.622.773.124.621.861.902.893.582.702.392.563.022.572.353.013.062.563.514.364.531.422.814.0213.2314.0816.3820.2120.253.703.645.494.5221.0818.363.002.622.961.59NA2.85NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Property Plant And Equipment Gross 140.30136.48139.36134.27128.52125.46123.34122.69122.36122.36122.28122.14128.76128.38126.61126.10127.36127.42127.42127.87128.08128.39128.50128.50167.44167.44167.46308.67316.76317.02314.00310.35309.07299.33289.92287.62285.21286.08285.39NA284.79NANANANANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 99.1298.5697.9197.6697.6797.3296.8496.8296.6296.1795.7795.36101.63101.24100.86100.50101.73101.39100.94100.95100.70100.47100.0299.58120.62120.02119.43119.51125.35123.15120.55118.22118.15115.80113.58111.06101.2599.4796.24NA91.76NANANANANANA
Property Plant And Equipment Net 41.1837.9241.4536.6130.8528.1426.5125.8725.7426.1926.5226.7827.1327.1525.7525.6025.6326.0426.4826.9227.3727.9228.4828.9346.8347.4248.0348.75191.41193.87193.45192.13190.92183.53176.34176.56183.96186.61189.16190.92193.03196.37200.38NA202.36NANA
Long Term Investments 12.7332.6070.5456.6242.0638.951.48NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Goodwill 3.072.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Intangible Assets Net Excluding Goodwill 1.171.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Noncurrent 17.3117.5112.068.196.095.803.053.273.604.014.356.19NANANA0.250.200.320.370.440.480.520.610.650.701.251.101.011.832.022.030.852.117.408.445.520.230.230.230.230.230.230.23NA0.32NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Liabilities Current 59.6059.5653.4948.3550.0360.4373.1273.70106.1267.9468.2565.6264.2976.9877.8775.2459.6374.9080.6787.6091.4785.8793.0592.05105.83289.71249.21268.32267.31342.25380.75403.35293.78119.2344.52127.79144.7851.7655.4434.4125.3617.3121.56NA18.13NANA
Accounts Payable Current 9.877.828.706.969.537.496.715.585.805.826.734.7911.667.536.985.385.829.244.986.985.286.541.523.265.092.850.5815.604.445.193.307.3917.395.093.643.864.553.175.822.664.621.601.60NA3.29NANA
Other Accrued Liabilities Current 2.983.332.471.981.311.561.200.860.800.590.861.300.371.570.981.030.811.070.960.590.720.500.800.350.203.112.191.413.093.043.397.5412.274.215.725.711.301.491.72NA1.09NANANANANANA
Accrued Liabilities Current 30.3533.1827.1327.4220.8322.4127.5919.7115.8114.7118.3315.9014.3016.4518.0615.0213.4314.0715.9312.4512.499.0810.667.9414.1610.258.087.9314.0813.9312.3826.2127.2720.5815.0121.6325.7848.6049.6231.7520.7415.7119.96NA14.84NANA
Contract With Customer Liability Current 1.791.671.310.8314.0220.1325.8833.2728.8732.1830.8432.5032.2132.3732.3836.88NANANA0.25NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Long Term Debt 273.02272.55281.67281.20280.73285.13330.59122.23121.83121.75119.02118.90118.7799.99102.49102.49105.48129.36140.27156.82NANANANANANANANANA244.90232.50NANANANANANANANANANANANANANANANA
Senior Notes 225.03224.67224.31223.94223.58223.22222.85NANANANA10.03NANANA19.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent NANA7.054.955.015.32NANANANANANANANANANANANANANANANANANA17.4016.6715.9515.2214.4912.1226.7815.3411.5715.0414.3213.61NANANANANANANANANANANA
Operating Lease Liability Noncurrent 5.675.930.831.040.800.560.871.201.521.842.152.512.753.093.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Stockholders Equity -237.68-247.06-232.06-209.35-184.69-183.55-173.62-180.42-186.42-179.71-198.05-190.53-184.71-196.00-188.00-175.08-205.44-206.62-223.21-214.73-251.01-221.24-198.72-183.59-238.69-366.58-373.46-350.33-124.57-115.47-97.03-73.77-40.68-46.3817.54-30.71-110.68-276.25-244.38-277.39-313.65-280.81-245.38NA-185.53NANA
Common Stock Value 2.632.572.522.522.502.502.492.422.312.292.132.122.061.891.881.871.591.461.261.191.051.050.964.784.784.784.294.294.184.124.094.064.053.963.873.702.862.001.991.681.311.311.31NA1.28NANA
Additional Paid In Capital Common Stock 2960.422936.672922.552918.202914.822911.532885.952866.302834.002829.482801.042799.282790.892769.402765.022763.072723.232698.032658.962638.992570.072566.962554.232549.212548.092546.732510.372508.632457.482434.782424.352416.972413.622371.492362.132262.001991.381774.891763.941694.661620.541616.981614.02NA1587.86NANA
Retained Earnings Accumulated Deficit -3199.52-3185.09-3156.07-3130.07-3102.01-3097.58-3062.06-3049.14-3022.73-3011.48-3001.22-2991.90-2977.64-2967.27-2954.88-2940.00-2930.25-2906.09-2883.41-2854.90-2822.11-2789.23-2753.89-2737.57-2791.54-2918.06-2888.10-2863.23-2586.21-2554.35-2525.45-2494.78NANANA-2296.40NANANANANANANANANANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -1.21-1.21-1.08NANANANANANANANA-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.01-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.01-0.01-0.00-0.00-0.00-0.01-0.01-0.01-0.000.040.040.04NA0.07NANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 3.624.422.81NA3.183.931.94NA1.292.191.13NA1.642.571.00NA1.562.211.94NANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities -28.07-31.98-18.25-12.35-15.18-21.45-12.730.23-13.46-3.68-11.22-5.11-52.05-19.73-11.6024.99-13.92-27.15-21.65-29.98-23.27NANANANANANANANANANANANANANA-34.05-28.10-34.26-25.02-32.49-20.36-36.03-36.74-30.70-38.97-34.85NA
Net Cash Provided By Used In Investing Activities 27.352.02-39.51-12.584.99-112.53-31.42-4.48-0.00-0.1519.85-0.203.76-1.37-25.03-0.24NANANA0.00NANANANANANANANANANANANANANANA-6.17-0.06-0.12-0.08-0.29-0.12-0.59-4.051.83-8.110.45NA
Net Cash Provided By Used In Financing Activities 19.53-1.780.8197.37-0.59-51.49224.9818.692.6428.190.335.0465.50-0.680.0035.97-1.8226.620.5358.24-0.02NANANANANANANANANANANANANANA17.2088.234.510.3986.450.3834.6518.659.7215.22103.97NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities -28.07-31.98-18.25-12.35-15.18-21.45-12.730.23-13.46-3.68-11.22-5.11-52.05-19.73-11.6024.99-13.92-27.15-21.65-29.98-23.27NANANANANANANANANANANANANANA-34.05-28.10-34.26-25.02-32.49-20.36-36.03-36.74-30.70-38.97-34.85NA
Net Income Loss -14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.17-22.68-30.39-32.78-32.89-35.34-16.3253.98126.52-29.96-24.87-277.02-31.86-28.91-30.66-36.44-36.52-73.36-52.06-53.58-51.78-42.83-36.58-38.17-36.40-38.40-44.48-41.52-38.31-45.30-42.25
Profit Loss -14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.16-22.68-30.39-32.78-32.89NANANANANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Receivable 8.465.214.83-4.453.142.73-0.650.080.77-1.811.66-0.58-0.881.22-0.261.26-0.101.30-1.130.980.490.870.14-2.813.14-0.140.12NANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Inventories -1.381.830.891.570.002.430.080.091.060.59-0.430.46-0.270.240.121.230.12-0.041.842.50-0.04-0.531.37-2.792.26NANA12.703.59NANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable 2.05-0.881.75-2.572.040.781.12-0.21-0.02-0.911.94-6.884.130.561.60-0.44-3.424.26-2.011.70-1.265.02-1.67-1.832.242.27-14.8011.11-0.461.95-4.18-10.0712.122.60-1.040.861.57-2.772.96-1.712.790.33-0.23-0.22-4.253.77NA
Share Based Compensation 3.624.422.813.163.183.931.941.901.292.191.130.891.642.671.001.141.562.211.941.081.251.251.271.001.501.351.272.352.601.772.001.87-4.8340.6510.9413.883.523.823.072.883.183.321.992.712.243.34NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Investing Activities 27.352.02-39.51-12.584.99-112.53-31.42-4.48-0.00-0.1519.85-0.203.76-1.37-25.03-0.24NANANA0.00NANANANANANANANANANANANANANANA-6.17-0.06-0.12-0.08-0.29-0.12-0.59-4.051.83-8.110.45NA
Payments To Acquire Property Plant And Equipment 0.27-2.835.065.194.251.050.980.500.000.150.150.110.961.220.27NANANANANANANANA0.000.000.001.140.321.234.534.204.969.478.261.416.170.070.120.120.320.150.594.121.993.941.55NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Financing Activities 19.53-1.780.8197.37-0.59-51.49224.9818.692.6428.190.335.0465.50-0.680.0035.97-1.8226.620.5358.24-0.02NANANANANANANANANANANANANANA17.2088.234.510.3986.450.3834.6518.659.7215.22103.97NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenues 32.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Cipla Ltd, License And Service, License And Distribution Agreement 0.040.040.040.040.040.040.040.040.040.040.040.040.040.040.04NA0.040.03NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Vertice Pharma L L C, License And Service, Co Promotion Agreement 0.000.30NA0.000.000.860.29NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product Sales 26.1817.42NANA9.759.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service 10.355.872.171.1812.4613.309.348.388.088.138.238.238.198.9412.3710.350.080.090.06NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 16.2612.729.8311.349.759.988.1010.067.286.998.007.766.406.075.085.734.393.753.404.471.981.55NANANANANANANANANANANANANANANANANANANANANANANANANA
Royalty 6.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Service 0.431.17NANA12.4613.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, Commercial Supply Agreement 9.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, License Agreement 0.390.701.350.6712.3112.169.008.287.987.987.987.977.867.787.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Other Agreement -0.000.110.090.160.080.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation 16.535.70NANA12.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Commercial Supply Agreement 9.924.70NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, License Agreement 0.390.70NANA12.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Royalties Arrangement 6.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 32.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Cipla Ltd, License And Service, License And Distribution Agreement 0.040.040.040.040.040.040.040.040.040.040.040.040.040.040.04NA0.040.03NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Vertice Pharma L L C, License And Service, Co Promotion Agreement 0.000.30NA0.000.000.860.29NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product Sales 26.1817.42NANA9.759.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service 10.355.872.171.1812.4613.309.348.388.088.138.238.238.198.9412.3710.350.080.090.06NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 16.2612.729.8311.349.759.988.1010.067.286.998.007.766.406.075.085.734.393.753.404.471.981.55NANANANANANANANANANANANANANANANANANANANANANANANANA
Royalty 6.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Service 0.431.17NANA12.4613.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, Commercial Supply Agreement 9.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, License Agreement 0.390.701.350.6712.3112.169.008.287.987.987.987.977.867.787.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Other Agreement -0.000.110.090.160.080.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation 16.535.70NANA12.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Commercial Supply Agreement 9.924.70NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, License Agreement 0.390.70NANA12.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Royalties Arrangement 6.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Stockholders Equity
Assets
Intangible Assets Net Excluding Goodwill
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Intangible Assets Net Excluding Goodwill
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Liabilities Current
Current Liabilities
Contract With Customer Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Businesses Net Of Cash Acquired
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
NonoperatingIncomeExpense
Nonoperating Income Expense
InventoryNet
Inventory Finished Goods Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:OperatingExpenses
us-gaap:ProductOrService
(None,)
Operating Expensesus-gaap: Product Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AccountsReceivableNetCurrent
us-gaap:ProductOrService
(None,)
Accounts Receivable Net Currentus-gaap: Product Or Service
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement